Merck & Co. (NYSE:MRK) is among a number of drug firms which “would love to get their hands” on Amarin Corporation (NASDAQ:AMRN) for Vascepa, says the Daily Mail, which also says that AstraZeneca (NYSE:AZN) could be readying a cash bid for the company as well. Other big pharma companies, such as Eli Lilly and Company (NYSE:LLY), Abbott Laboratories (NYSE:ABT) and Pfizer could get into the action.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>